Candriam SCA’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $23.9M | Buy |
83,211
+3,998
| +5% | +$1.15M | 0.14% | 144 |
|
|
2025
Q1 | $24.4M | Buy |
79,213
+4,606
| +6% | +$1.42M | 0.15% | 139 |
|
|
2024
Q4 | $26.3M | Buy |
74,607
+7,459
| +11% | +$2.63M | 0.15% | 135 |
|
|
2024
Q3 | $24.1M | Buy |
67,148
+2,635
| +4% | +$944K | 0.14% | 151 |
|
|
2024
Q2 | $20.5M | Buy |
64,513
+61,573
| +2,094% | +$19.6M | 0.12% | 163 |
|
|
2024
Q1 | $675K | Sell |
2,940
-433
| -13% | -$99.5K | ﹤0.01% | 634 |
|
|
2023
Q4 | $742K | Buy |
3,373
+389
| +13% | +$85.5K | 0.01% | 625 |
|
|
2023
Q3 | $674K | Hold |
2,984
| – | – | ﹤0.01% | 601 |
|
|
2023
Q2 | $659K | Sell |
2,984
-4,597
| -61% | -$1.01M | ﹤0.01% | 663 |
|
|
2023
Q1 | $1.56M | Buy |
+7,581
| New | +$1.56M | 0.01% | 627 |
|
|
2018
Q4 | – | Sell |
-2,800
| Closed | -$358K | – | 848 |
|
|
2018
Q3 | $358K | Buy |
+2,800
| New | +$358K | ﹤0.01% | 744 |
|
|
2018
Q2 | – | Sell |
-4,142
| Closed | -$465K | – | 826 |
|
|
2018
Q1 | $465K | Hold |
4,142
| – | – | 0.01% | 685 |
|
|
2017
Q4 | $613K | Buy |
4,142
+1,919
| +86% | +$284K | 0.01% | 648 |
|
|
2017
Q3 | $261K | Sell |
2,223
-1,310
| -37% | -$154K | ﹤0.01% | 703 |
|
|
2017
Q2 | $458K | Sell |
3,533
-10,467
| -75% | -$1.36M | 0.01% | 665 |
|
|
2017
Q1 | $1.9M | Hold |
14,000
| – | – | 0.04% | 456 |
|
|
2016
Q4 | $2.01M | Hold |
14,000
| – | – | 0.05% | 369 |
|
|
2016
Q3 | $1.65M | Hold |
14,000
| – | – | 0.04% | 395 |
|
|
2016
Q2 | $1.48M | Sell |
14,000
-4,000
| -22% | -$424K | 0.04% | 360 |
|
|
2016
Q1 | $2M | Sell |
18,000
-15,100
| -46% | -$1.67M | 0.05% | 322 |
|
|
2015
Q4 | $5.18M | Sell |
33,100
-7,000
| -17% | -$1.1M | 0.14% | 170 |
|
|
2015
Q3 | $5.26M | Sell |
40,100
-3,900
| -9% | -$512K | 0.13% | 193 |
|
|
2015
Q2 | $7.65M | Buy |
44,000
+8,000
| +22% | +$1.39M | 0.16% | 175 |
|
|
2015
Q1 | $6.21M | Buy |
36,000
+7,000
| +24% | +$1.21M | 0.13% | 212 |
|
|
2014
Q4 | $3.76M | Buy |
+29,000
| New | +$3.76M | 0.08% | 282 |
|